Di Wang
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Anti-BCMA CAR-T therapy in patients with progressive multiple sclerosis.
Journal: Cell
Published: January 29, 2025
Case report: Light-chain amyloidosis responsive to selinexor in combination with daratumumab and dexamethasone (SDd) therapy.
Journal: Frontiers in medicine
Published: December 31, 2023
B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis.
Journal: EMBO molecular medicine
Published: September 23, 2023
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results.
Journal: Signal transduction and targeted therapy
Published: October 01, 2022
A Model Perspective Explanation of the Long-Term Sustainability of a Fully Human BCMA-Targeting CAR (CT103A) T-Cell Immunotherapy.
Journal: Frontiers in pharmacology
Published: October 28, 2021
Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function.
Journal: Current medical science
Published: April 16, 2021
A phase I study of anti-BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia.
Journal: Clinical and translational medicine
Published: August 01, 2020
Establishment of xenotransplated mouse model using primary multiple myeloma cells
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: July 12, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026